SIG
47
-2
HCP
70
-4
STZ
58
3
TAP
64
4
LOW
58
2
KLAC
45
-4
EFX
41
-2
DFS
67
-3
LEN
52
2
URBN
66
2
PG
50
2
DVN
29
4
NWSA
71
-2
UA
57
4
ACN
70
5
DLTR
40
4
MMM
42
5
DOW
30
2
PSA
58
5
GPC
40
2
SIG
47
-2
HCP
70
-4
STZ
58
3
TAP
64
4
LOW
58
2
KLAC
45
-4
EFX
41
-2
DFS
67
-3
LEN
52
2
URBN
66
2
PG
50
2
DVN
29
4
NWSA
71
-2
UA
57
4
ACN
70
5
DLTR
40
4
MMM
42
5
DOW
30
2
PSA
58
5
GPC
40
2
Financhill
Back

Prelude Therapeutics Vs. Merck & Industry Stock Comparison

Sell
19

PRLD
Prelude Therapeutics

Last Price:
1.03
Seasonality Move:
21.44%
Sell
22

MRK
Merck &

Last Price:
98.29
Seasonality Move:
3.3%
Sell
19
Prelude Therapeutics (PRLD) is a Sell

Is Prelude Therapeutics a Buy, Sell or Hold?

  • The current Prelude Therapeutics [PRLD] share price is $1.06. The Score for PRLD is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • PRLD is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
22
Merck & (MRK) is a Sell

Is Merck & a Buy, Sell or Hold?

  • The current Merck & [MRK] share price is $98.50. The Score for MRK is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
  • MRK is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

PRLD Stock Price Chart

What is Prelude Therapeutics's stock price today?

  • The Prelude Therapeutics share price today is $1.06
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PRLD is experiencing selling pressure, which indicates risk of future bearish movement.

MRK Stock Price Chart

What is Merck &'s stock price today?

  • The Merck & share price today is $98.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MRK is experiencing slight selling pressure.

PRLD Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.32 Sell
Relative Strength Index (14 RSI): 21.5 Sell
Chaikin Money Flow: -457523 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.21 - 1.83) Sell
Bollinger Bands (100): (1.92 - 5.38) Sell

MRK Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.96 Sell
Relative Strength Index (14 RSI): 26.38 Sell
Chaikin Money Flow: -1992532 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (101.06 - 108.7) Sell
Bollinger Bands (100): (107 - 123.8) Sell

PRLD Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.21 Sell
20-day SMA: 1.42 Sell
50-day SMA: 2.27 Sell
200-day SMA: 3.86 Sell
8-day EMA: 1.21 Sell
20-day EMA: 1.44 Sell
50-day EMA: 2.23 Sell
200-day EMA: 3.56 Sell

MRK Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 100.77 Sell
20-day SMA: 103.57 Sell
50-day SMA: 109.79 Sell
200-day SMA: 121.37 Sell
8-day EMA: 100.67 Sell
20-day EMA: 103.39 Sell
50-day EMA: 108.36 Sell
200-day EMA: 115.88 Sell

Prelude Therapeutics Earnings Growth & PRLD Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.25 per share, and an increase next year of $0.31 per share.

Merck & Earnings Growth & MRK Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.98 per share, a decrease next quarter of $0.00 per share, an increase this year of $6.46 per share, and an increase next year of $1.67 per share.

Prelude Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Merck & Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):